10.1007/s00125-016-3874-y 40 FlintA.KapitzaC.HindsbergerC.ZdravkovicM
Both medications carry important safety warnings: Adderall has a boxed warning regarding abuse and dependence potential, while semaglutide products carry a boxed warning about thyroid C-cell tumor risk
What are the key trends defining the market
Combined with baseline biomarkersfasting glucose, insulin resistance, lipid profile, inflammatory markersgenetic insights support a more informed conversation about treatment selection, expected tolerability, and monitoring needs during therapy
Conversely, no significant changes were seen in FSH, LH, or estradiol across the study period, suggesting that the primary hormonal effects of the intervention were centered on IGF-1 and testosterone [2]
Get lab work if needed